The tablets (250 mg lactoferrin) on oral mucosa of human volunteers were able to keep the lactoferrin concentration in the saliva for at least 2 h, suggesting that they might improve the therapeutic efficacy of lactoferrin in oral candidiasis treatment (Kuipers et al., 2002). The gene discussed is LTF; the disease is oral candidiasis.